Can matching treatment to genetic risk beat relapsed childhood leukemia?
⭐️ CURE ⭐️
Recruiting now
This trial is testing whether a treatment plan tailored to each child's genetic risk can improve outcomes for relapsed acute lymphoblastic leukemia. Children and young adults up to age 22 whose leukemia has returned in the bone marrow receive a combination of chemotherapy drugs, …
Phase: PHASE2 • Sponsor: Ho Joon Im • Aim: ⭐️ CURE ⭐️
Last updated Jul 31, 2026 00:00 UTC